StockData
IDEXX Laboratories Inc logo

IDEXX Laboratories Inc (IDXX) stock

IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3036% above fair value
$690.24−10.41 (-1.49%)

Close on Nov 17, 2026Market cap $54.38BP/E 48.5Yield –

IDEXX Laboratories profit margin

Profit margin (net margin) is net income as a percentage of revenue.

IDEXX Laboratories's profit margin for the twelve months ending Jun 30, 2026 was 25.0%. For fiscal 2025 it was 24.6%, against 22.8% the year before. The highest annual figure on record is 24.6% in fiscal 2025.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202524.6%+1.8
FY2024Dec 31, 202422.8%−0.3
FY2023Dec 31, 202323.1%+2.9
FY2022Dec 31, 202220.2%−3.0
FY2021Dec 31, 202123.2%+1.7
FY2020Dec 31, 202021.5%+3.7
FY2019Dec 31, 201917.8%+0.7
FY2018Dec 31, 201817.0%+3.7
FY2017Dec 31, 201713.4%+0.9
FY2016Dec 31, 201612.5%+0.5
FY2015Dec 31, 201512.0%−0.3
FY2014Dec 31, 201412.2%−1.4
FY2013Dec 31, 201313.6%−0.1
FY2012Dec 31, 201213.8%+0.5
FY2011Dec 31, 201113.3%+0.5
FY2010Dec 31, 201012.8%+1.0
FY2009Dec 31, 200911.8%+0.5
FY2008Dec 31, 200811.3%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202627.8%+1.3
Q1 FY2026Mar 31, 202624.4%+0.1
Q4 FY2025Dec 31, 202522.8%+0.1
Q3 FY2025Sep 30, 202524.8%+1.0
Q2 FY2025Jun 30, 202526.5%+6.2
Q1 FY2025Mar 31, 202524.3%−0.1
Q4 FY2024Dec 31, 202422.7%+1.1
Q3 FY2024Sep 30, 202423.9%+0.7
Q2 FY2024Jun 30, 202420.3%−3.5
Q1 FY2024Mar 31, 202424.4%+0.7
Q4 FY2023Dec 31, 202321.6%+0.8
Q3 FY2023Sep 30, 202323.2%+1.7
Q2 FY2023Jun 30, 202323.8%+8.4
Q1 FY2023Mar 31, 202323.8%+0.6
Q4 FY2022Dec 31, 202220.8%+0.5
Q3 FY2022Sep 30, 202221.5%−0.1
Q2 FY2022Jun 30, 202215.3%−9.2
Q1 FY2022Mar 31, 202223.2%−3.1
Q4 FY2021Dec 31, 202120.3%−3.9
Q3 FY2021Sep 30, 202121.6%+1.4
Q2 FY2021Jun 30, 202124.5%+1.2
Q1 FY2021Mar 31, 202126.3%+8.4
Q4 FY2020Dec 31, 202024.2%+9.3
Q3 FY2020Sep 30, 202020.3%+2.3
Q2 FY2020Jun 30, 202023.4%+3.1
Q1 FY2020Mar 31, 202017.9%+0.0
Q4 FY2019Dec 31, 201914.9%−0.6
Q3 FY2019Sep 30, 201918.0%+0.9
Q2 FY2019Jun 30, 201920.3%+1.6
Q1 FY2019Mar 31, 201917.8%+1.2
Q4 FY2018Dec 31, 201815.6%+8.0
Q3 FY2018Sep 30, 201817.1%+2.8
Q2 FY2018Jun 30, 201818.7%+1.9
Q1 FY2018Mar 31, 201816.6%+1.7
Q4 FY2017Dec 31, 20177.6%−4.3
Q3 FY2017Sep 30, 201714.3%+1.7
Q2 FY2017Jun 30, 201716.8%–
Q1 FY2017Mar 31, 201714.9%–
Q4 FY2016Dec 31, 201611.8%–
Q3 FY2016Sep 30, 201612.6%–

More IDEXX Laboratories figures

See a number that looks wrong?